Page 2 - Best Osteosarcoma doctors in Turkey: TOP 35 doctors

Associate Professor Ozatli specializes in breast, lung, and gastrointestinal cancers – bringing deep expertise to osteosarcoma treatment at Istinye Liv University Hospital.

• Internal Medicine Specialist with extensive oncology experience
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Nail Paksoy is an Associate Professor specializing in osteosarcoma and other sarcomas, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Published multiple studies on osteosarcoma treatments
• Affiliated with Istanbul Medipol University's Oncology Department
• Participated in international clinical trials for sarcoma treatments

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Murat Ayhan specializes in advanced treatments for bone cancers, including innovative immunotherapy and targeted therapies at Liv Hospital Vadistanbul.

• Associate Professor of Medical Oncology with extensive research in cancer treatments
• Active participant in international clinical trials for breast, lung, and colorectal cancers
• Author of several medical publications and book chapters on oncology
• Member of European Society of Medical Oncology (ESMO) and Turkish Society of Medical Oncology (TTOD)

Specialized in radiation oncology at Marmara University – a leading medical institution in Turkey.

• Completed rigorous training in radiation oncology from 2012 to 2016
• Graduated from Marmara University Faculty of Medicine (English program)
• Works at Emsey Hospital, a modern healthcare facility

Associate Professor Dr. Emrah Eraslan specializes in medical oncology with a focus on osteosarcoma at Private Koru Ankara Hospital.

• Over 21 years of experience of experience in internal medicine and medical oncology
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Published multiple research papers contributing to oncology field
• Current associate professor with active clinical practice

Professor Kayihan Engin specializes in radiation oncology with a focus on osteosarcoma, bringing decades of expertise from prestigious institutions like Thomas Jefferson University.

• Over 41 years of experience of experience in radiation oncology
• Former Chairman of Radiation Oncology at Uludağ University
• Post-doctoral fellowship in Thermoradiotherapy at Thomas Jefferson University
• Director of Oncological Sciences at Medicana Bursa Hospital